G. Le Guenno

4.7k citations
49 papers · 946 indexed · h-index 16
Topics
Vasculitis and related conditions (9 papers)Sarcoidosis and Beryllium Toxicity Research (8 papers)Platelet Disorders and Treatments (8 papers)

In The Last Decade

G. Le Guenno

42 papers receiving 925 citations

Peers

G. Le Guenno
Comparison fields: 5 of 68
  • Rheumatology 322
  • Pulmonary and Respiratory Medicine 321
  • Physiology 286
  • Hematology 240
  • Genetics 219
Replace Ann Knight with:
Ann Knight Sweden
H. Devilliers France
J.E. Gottenberg France
Kyriaki Boki Greece
Žiga Rotar Slovenia
R. Pérez-Álvarez Spain
Sandra Muñoz Spain
G. Maigné France
Karin Manger Germany
Daiki Nakagomi Japan
G. Le Guenno relative to Ann Knight Sweden Ann Knight's profile →
Citations per field
00.5×3.3×
Ann Knight · 1×
Citations per year

Countries citing papers authored by G. Le Guenno

Since Specialization
Citations

This map shows the geographic impact of G. Le Guenno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Le Guenno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Le Guenno more than expected).

Fields of papers citing papers by G. Le Guenno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Le Guenno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Le Guenno. The network helps show where G. Le Guenno may publish in the future.

Co-authorship network of co-authors of G. Le Guenno

This figure shows the co-authorship network connecting the top 25 collaborators of G. Le Guenno. A scholar is included among the top collaborators of G. Le Guenno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Le Guenno. G. Le Guenno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 9
5 3
6
Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.
1
7 19
8 6
9 11
10 6
11 1
12 15
13 53
14 9
15 47
16 125
17 18
18 2
19 56
20 57

About G. Le Guenno

G. Le Guenno is a scholar working on Hematology, Rheumatology and Physiology, having authored 49 papers that have together received 946 indexed citations. Recurring topics across this work include Vasculitis and related conditions (9 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Platelet Disorders and Treatments (8 papers). The work is most often cited by research in Hematology (240 citations), Rheumatology (322 citations) and Genetics (219 citations). G. Le Guenno has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include M. Ruivard, Alfred Mahr, V. Rieu, Loı̈c Guillevin, Mikkel Faurschou, Caroline Heijl, Vincent Grobost, Lionel Galicier, Béatrice Morio and Andrzej Mazur. Their work appears in journals such as Blood, Neurology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026